Abstract: A method of increasing a prostate specific antigen (PSA) doubling time in treating a patient. A subject with rising serum PSA is selected. A composition is administered to the subject comprising a therapeutically effective amount of a pomegranate extract comprising a higher content of high molecular weight polyphenol compared to pomegranate juice from arils. The therapeutically effective amount increases a prostate specific antigen doubling time. The pomegranate extract is formed from an insoluble byproduct component obtained by placing pomegranate solids in an aqueous solution, heating the aqueous solution to between about 60° F. to about 210° F., adding at least one enzyme to the aqueous solution, and removing residual insoluble solid materials from the aqueous solution.

Abstract: Processes for producing an extract containing phytochemicals from pomegranates are disclosed. The processes generally comprise providing pomegranate solids, such as the pericarp, inner membrane and seeds; creating a mixture comprising the pomegranate solids in an aqueous solution; adding enzymes to the mixture in an amount sufficient to at least partially degrade the pomegranate solids; heating the mixture to a temperature that permits the maximum rate of catalysis of the enzyme; maintaining the temperature of the heated mixture for a time sufficient to allow at least partial degradation of the pomegranate solids; and removing residual insoluble solid materials from the mixture. Compositions containing the extract may be used as a food product, beverage, pharmaceutical preparations, nutritional supplements, vitamin supplements, food additives, and food supplements.

Abstract: A pomegranate beverage including a pomegranate juice component prepared by crushing and squeezing whole fruits of pomegranate including inner and outer peels and seeds to yield a juice component and an insoluble by-product component, where the juice component separated from the insoluble by-product component to obtain the pomegranate juice component, and an amount of a pomegranate extract component including at least 30 to 3000 ?mols of polyphenols, where the beverage is prepared by a process including re-suspending the insoluble by-product component in an aqueous medium, mixing the re-suspended insoluble by-product component and the aqueous medium, and separating an aqueous extract from the insoluble by-product component to obtain the pomegranate extract component, where the aqueous extract includes polyphenols resulting from the insoluble by-product component.

Abstract: One or more embodiments of the invention are directed to methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans. The methods comprise the step of administering to the patients a composition comprising a therapeutically effective amount of an extract from pomegranate.

Abstract: A cosmetic composition is provided having ingredients that may prevent signs or conditions of aging and/or damage in skin, improve the aesthetic appearance of skin, and promote recovery from environmental stresses. The composition includes natural ingredients, including pomegranate juice concentrate; pomegranate extract; pomegranate seed oil; and at least one pharmaceutically or cosmetically acceptable vehicle.

Abstract: The present invention provides a method, composition and product by process of pomegranate seed oil. The present invention provides a novel method for the preparation of pomegranate seeds and the subsequent extraction, stabilization and deodorization of pomegranate seed oil. The process maintains key beneficial components of pomegranate seed oil. Effective processing parameters for separating, drying, cleaning, flaking, obtaining the oil from seeds, stabilizing through refining and bleaching and deodorizing the oil are described.

Abstract: An identification system includes a clamshell device that grasps a wire, and a clip that secures the clamshell device in a locked and closed position. The clamshell and/or clip are preferably color-coded to differentiate one wire from another, hereby allowing a technician to easily discern which wire is plugged into which port, and which wire is connected to which patient. The invention is particularly well suited for incorporation with healthcare devices and machines which have long lead wires that reach from the patient to the machine, such as electrical stimulation machines.

Abstract: Nutraceutical compositions for improved administration of important phytochemicals from pomegranate to a human or animal. More particularly, enables oral or enteral dosage forms containing phytochemicals from pomegranate for administering on a routine basis. In at least one instance the natural contents of a pomegranate are encapsulated into a pill form or concentrated juice that provides for more efficient administration than eating a pomegranate but contains the same key ingredients present in the fruit. Enables the recipient to receive the benefits of the fruit but allows for the dosages to be taken in pill or concentrated juice form. Composition is chemically similar or equal to a natural pomegranate but is in a powder, pill or concentrated liquid form.

Abstract: One or more embodiments of the invention are directed to methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans. The methods comprise the step of administering to the patients a composition comprising a therapeutically effective amount of an extract from pomegranate.

Abstract: Nutraceutical compositions for improved administration of important phytochemicals from pomegranate to a human or animal. More particularly, enables oral or enteral dosage forms containing phytochemicals from pomegranate for administering on a routine basis. In at least one instance the natural contents of a pomegranate are encapsulated into a pill form or concentrated juice that provides for more efficient administration than eating a pomegranate but contains the same key ingredients present in the fruit. Enables the recipient to receive the benefits of the fruit but allows for the dosages to be taken in pill or concentrated juice form. Composition is chemically similar or equal to a natural pomegranate but is in a powder, pill or concentrated liquid form.

Abstract: The present invention relates generally to the processing of fluids and/or their carriers. Carriers may comprise pipes, tubes and the like or reservoirs for the distribution and/or storage of fluids. In one form, the present invention relates to a method and apparatus that is suitable for use in the treatment of various fluids, such as water, by introducing at least one chemically active metal into the water and its carriers for disinfection of the water in a controlled manner. The invention also relates to a biasing means for displacement of an electrode arrangement to allow for the introduction of ions into a fluid at a controlled or easily monitored rate that is commensurate with the amount of fluid flow.

Abstract: One or more embodiments of the invention are directed to methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans. The methods comprise the step of administering to the patients a composition comprising a therapeutically effective amount of an extract from pomegranate.

Abstract: Methods and compositions for treating at least one symptom of a viral infection, said method of treatment comprising administering to a subject with a least one symptom of a viral infection an effective dosage unit of a composition comprising pomegranate extract. The compositions comprise pomegranate extract comprising polyphenols. The composition is produced by a process comprising providing one or more pomegranate solids selected from the group consisting of a pericarp, inner membrane and seeds, creating a mixture comprising said one or more pomegranate solids in an aqueous solution, heating said mixture to a temperature that permits enzyme catalysis of said pomegranate solids, and removing residual insoluble solid materials from said mixture to provide said pomegranate extract. Compositions containing the extract may be used as a food product, beverage, pharmaceutical preparations, nutritional supplements, vitamin supplements, food additives, and food supplements.

Abstract: A method of increasing a prostate specific antigen (PSA) doubling time in treating a patient. A subject with rising serum PSA is selected. A composition is administered to the subject comprising a therapeutically effective amount of a pomegranate extract comprising a higher content of high molecular weight polyphenol compared to pomegranate juice from arils. The therapeutically effective amount increases a prostate specific antigen doubling time. The pomegranate extract is formed from an insoluble byproduct component obtained by placing pomegranate solids in an aqueous solution, heating the aqueous solution to between about 60° F. to about 210° F., adding at least one enzyme to the aqueous solution, and removing residual insoluble solid materials from the aqueous solution.

Abstract: A high-durability cam wheel assembly mounted in a shell of a refrigerant recovery machine is disclosed to include a frame member (1) having rails (12) mounted therein, a sliding block (2) mounted inside the frame member (1) and having a plurality of sliding grooves (21) extending around the periphery thereof and kept in contact with the rails (12) of the frame member (1), and a cam wheel set (3) consisting of a first cam wheel (31) and a second cam wheel (32) arranged at two opposite sides relative to the sliding block (2) and connected to each other in an axle bearing (23) inside the sliding block (2).

Abstract: A method of increasing a prostate specific antigen (PSA) doubling time in treating a patient. A subject with rising serum PSA is selected. A composition is administered to the subject comprising a therapeutically effective amount of a pomegranate extract comprising a higher content of high molecular weight polyphenol compared to pomegranate juice from arils. The therapeutically effective amount increases a prostate specific antigen doubting time. The pomegranate extract is formed from an insoluble byproduct component obtained by placing pomegranate solids in an aqueous solution, heating the aqueous solution to between about 60° F. to about 210° F., adding at least one enzyme to the aqueous solution, and removing residual insoluble solid materials from the aqueous solution.

Abstract: A quick-release coupling includes a socket defining a first passage in a connection port thereof, a locking member mounted in a front end of the socket and adapted for locking an inserted external male mating connector, an air valve control device mounted in a rear end of the socket, and a leak-proof device, which includes a stopper mounted in the front end of the socket and defining an axially extending second passage and a transversely extending third passage and a plurality of gasket rings mounted around the stopper at two opposite lateral sides of the third passage for allowing fluid communication between the first passage and the second and third passages or blocking the first passage from the second and third passage after movement of the stopper relative to the socket between two positions.

Abstract: A quick-release coupling includes a socket defining a first passage in a connection port thereof, a locking member mounted in a front end of the socket and adapted for locking an inserted external male mating connector, an air valve control device mounted in a rear end of the socket, and a leak-proof device having a stopper mounted in the front end of the socket and defining therein a second passage, which is kept in communication with the first passage upon insertion of an external mating male connector into the front end of the socket to move the stopper backward, or blocked from the first passage after removable of the inserted external mating male connector and a forward movement of the stopper by the air valve control device.

Abstract: An indirect communication system and a method of indirect communication include a mobile phone as either a calling device or receiving device. The mobile phone calls another device to set up a prospective communication, and then uses Voice over Internet Protocol (VoIP) to communicate with the other device over the Internet. The receiving device receives a generated signal notifying the receiving device of a proposed communication with the calling device. A server sets up a meeting point channel after the calling device has connected to the server. The server receives outgoing VoIP packets from the calling device and redirects the outgoing VoIP packets to the receiving device.